Phone:
+1 877 302 8632
Fax:
+1 888 205 9894 (Toll-free)
E-Mail:
orders@antibodies-online.com

Recombinant HLA-DR antibody

The Mouse Monoclonal anti-HLA-DR antibody (Clone L243) (ABIN7795429) specifically detects HLA-DR in FACS. The antibody is reactive with Human samples.
Catalog No. ABIN7795429
$128.85
Plus shipping costs $50.00
100 μg
Shipping to: United States
Delivery in 11 to 17 Business Days

Quick Overview for Recombinant HLA-DR antibody (ABIN7795429)

Target

HLA-DR

Antibody Type

Recombinant Antibody

Reactivity

  • 162
  • 20
  • 17
  • 16
  • 16
  • 13
  • 11
  • 8
  • 6
  • 4
  • 2
  • 1
Human

Host

  • 118
  • 36
  • 10
  • 3
Mouse

Clonality

  • 159
  • 6
  • 1
Monoclonal

Conjugate

  • 76
  • 16
  • 16
  • 10
  • 8
  • 4
  • 2
  • 2
  • 2
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
This HLA-DR antibody is un-conjugated

Application

  • 114
  • 52
  • 45
  • 25
  • 24
  • 16
  • 12
  • 10
  • 10
  • 8
  • 5
  • 5
  • 5
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
Flow Cytometry (FACS)

Clone

L243
  • Expression System

    Mammalian cells

    Purpose

    Recombinant Anti-human HLA-DR Monoclonal Antibody (Clone: L243), Mouse IgG2a Kappa

    Characteristics

    The in vivo grade recombinant anti-human HLA-DR Mouse IgG2a Kappa monoclonal antibody was produced in mammalian cells.

    Purification

    Protein A or G affinity column

    Purity

    >95 % by reducing SDS-PAGE

    Isotype

    IgG2a
  • Application Notes

    Optimal working dilution should be determined by the investigator.

    Restrictions

    For Research Use only
  • Format

    Liquid

    Concentration

    > 3 mg/mL

    Storage

    4 °C,-20 °C

    Storage Comment

    Short time 2 to 8°C as supplied. Long time -20°C to -70°C as supplied.
  • Target

    HLA-DR

    Alternative Name

    HLA-DR

    Pathways

    Human Leukocyte Antigen (HLA) in Adaptive Immune Response
You are here:
Chat with us!